Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 84 Breast Neoplasms 34 Colorectal Neoplasms 26 Lung Neoplasms 23 Rectal Neoplasms 22 Neoplasms 21 Esophageal Squamous Cell Carcinoma 20 Neoplasm Metastasis 19 Esophageal Neoplasms 19 Head and Neck Neoplasms 17 Stomach Neoplasms 15 Pancreatic Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Triple Negative Breast Neoplasms 12 Small Cell Lung Carcinoma 12 Ovarian Neoplasms 11 Recurrence 10 Nasopharyngeal Carcinoma 10 Carcinoma, Squamous Cell 10 Uterine Cervical Neoplasms 9 Leukemia, Myeloid, Acute 9 Colonic Neoplasms 9 Glioblastoma 8 Prostatic Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma 7 Sarcoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Melanoma 6 Lymphoma, Non-Hodgkin 6

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × HER2 Negative Breast Cancer × Drug Therapy × Clear all

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡